Anna J. MacCamy

1.9k total citations
7 papers, 287 citations indexed

About

Anna J. MacCamy is a scholar working on Immunology, Virology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Anna J. MacCamy has authored 7 papers receiving a total of 287 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 3 papers in Virology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Anna J. MacCamy's work include HIV Research and Treatment (3 papers), T-cell and B-cell Immunology (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Anna J. MacCamy is often cited by papers focused on HIV Research and Treatment (3 papers), T-cell and B-cell Immunology (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Anna J. MacCamy collaborates with scholars based in United States, South Africa and Netherlands. Anna J. MacCamy's co-authors include Andrew T. McGuire, Leonidas Stamatatos, Marie Pancera, Yu-Hsin Wan, Leah J. Homad, Madeleine F. Jennewein, Nicholas K. Hurlburt, Junli Feng, K. Rachael Parks and Emilie Seydoux and has published in prestigious journals such as Immunity, Journal of Virology and Science Advances.

In The Last Decade

Anna J. MacCamy

6 papers receiving 285 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna J. MacCamy United States	4	244	83	70	52	38	7	287
K. Rachael Parks United States	6	214 0.9×	90 1.1×	85 1.2×	63 1.2×	25 0.7×	8	297
Pan-Pan Zhou China	8	252 1.0×	91 1.1×	47 0.7×	45 0.9×	60 1.6×	12	327
Chengzi I. Kaku United States	7	230 0.9×	52 0.6×	93 1.3×	32 0.6×	38 1.0×	9	276
Ludivine Grzelak France	7	194 0.8×	54 0.7×	100 1.4×	22 0.4×	19 0.5×	10	298
Wenxu Jia China	5	207 0.8×	84 1.0×	29 0.4×	42 0.8×	53 1.4×	6	281
Fernando Senjobe United States	5	259 1.1×	99 1.2×	72 1.0×	12 0.2×	22 0.6×	5	306
Elisa Pantano Italy	7	347 1.4×	107 1.3×	56 0.8×	41 0.8×	52 1.4×	8	380
Rhoda Tano-Menka United States	4	203 0.8×	83 1.0×	67 1.0×	9 0.2×	12 0.3×	5	234
Christiane Pallas Germany	6	339 1.4×	102 1.2×	28 0.4×	28 0.5×	26 0.7×	10	371
Clarety Kaseke United States	4	205 0.8×	80 1.0×	65 0.9×	8 0.2×	13 0.3×	5	231

Countries citing papers authored by Anna J. MacCamy

Since Specialization

Citations

This map shows the geographic impact of Anna J. MacCamy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna J. MacCamy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna J. MacCamy more than expected).

Fields of papers citing papers by Anna J. MacCamy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna J. MacCamy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna J. MacCamy. The network helps show where Anna J. MacCamy may publish in the future.

Co-authorship network of co-authors of Anna J. MacCamy

This figure shows the co-authorship network connecting the top 25 collaborators of Anna J. MacCamy. A scholar is included among the top collaborators of Anna J. MacCamy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna J. MacCamy. Anna J. MacCamy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Agrawal, Parul, Maria L. Knudsen, Anna J. MacCamy, et al.. (2024). Short CDRL1 in intermediate VRC01-like mAbs is not sufficient to overcome key glycan barriers on HIV-1 Env. Journal of Virology. 98(10). e0074424–e0074424.

2.

Gray, Matthew D., Junli Feng, Connor Weidle, et al.. (2022). Characterization of a vaccine-elicited human antibody with sequence homology to VRC01-class antibodies that binds the C1C2 gp120 domain. Science Advances. 8(18). eabm3948–eabm3948. 2 indexed citations

3.

Hurlburt, Nicholas K., Leah J. Homad, Irika R. Sinha, et al.. (2022). Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit. Communications Biology. 5(1). 342–342. 48 indexed citations

4.

Knudsen, Maria L., Parul Agrawal, Anna J. MacCamy, et al.. (2022). Adjuvants influence the maturation of VRC01-like antibodies during immunization. iScience. 25(11). 105473–105473. 2 indexed citations

5.

Seydoux, Emilie, Yu-Hsin Wan, Junli Feng, et al.. (2021). Development of a VRC01-class germline targeting immunogen derived from anti-idiotypic antibodies. Cell Reports. 35(5). 109084–109084. 10 indexed citations

6.

Seydoux, Emilie, Leah J. Homad, Anna J. MacCamy, et al.. (2020). Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation. Immunity. 53(1). 98–105.e5. 206 indexed citations

7.

Parks, K. Rachael, Anna J. MacCamy, Matthew D. Gray, et al.. (2019). Overcoming Steric Restrictions of VRC01 HIV-1 Neutralizing Antibodies through Immunization. Cell Reports. 29(10). 3060–3072.e7. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact